Age-related macular degeneration
Conditions
Interventions
Control from Hong Kong:N/A
PCV from Hong Kong:N/A
nAMD from Hong Kong:N/A
Control from France:N/A
PCV from France:N/A
nAMD from France:N/A
Sponsors
The Chinese University of Hong Kong Eye Centre
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients: All AMD patients recruited in this study have neovascular AMD in at least one eye. PCV is diagnosed upon a choroidal origin of polypoidal lesions. Diagnosis of neovascular AMD and PCV are distinguished by fluorescein angiography and ICGA. Subjects with any eye having neovascular AMD and PCV lesions concurrently or other causes of CNV were/will be excluded. Controls: Control subjects were recruited from people who attended the clinic for cataract surgery and included according to the following criteria: (1) age >= 60 years; (2) no identifiable signs of AMD or macular degeneration of any cause; and (3) no any other major eye diseases, except for mild refractive errors.
Exclusion criteria
Exclusion criteria: Patients who also have other major eye diseases such as glaucoma, diabetic retinopathy, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biomarkers; | — |
Countries
China
Contacts
Public ContactDr Chu Wai Kit
Department of Ophthalmology and Visual Sciences, Chinese University of Hong Kong
Outcome results
None listed